Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantation

Detalles Bibliográficos
Autores principales: Lorentino, Francesca, Xue, Elisabetta, Mastaglio, Sara, Giglio, Fabio, Clerici, Daniela, Farina, Francesca, Piemontese, Simona, Bruno, Alessandro, Lazzari, Lorenzo, Ruggeri, Annalisa, Guggiari, Elena, Lunghi, Francesca, Assanelli, Andrea A., Marktel, Sarah, Marcatti, Magda, Carrabba, Matteo G., Bernardi, Massimo, Corti, Consuelo, Peccatori, Jacopo, Ciceri, Fabio, Greco, Raffaella, Lupo-Stanghellini, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131907/
https://www.ncbi.nlm.nih.gov/pubmed/35078219
http://dx.doi.org/10.1182/bloodadvances.2021006213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131907/
https://www.ncbi.nlm.nih.gov/pubmed/35078219
http://dx.doi.org/10.1182/bloodadvances.2021006213

Ejemplares similares